Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 307-312 , December 2005

Buprenorphine tablet versus liquid: A clinical trial comparing plasma levels, efficacy, and symptoms

  • Marek C. Chawarski, Ph.D.

      Affiliations

    • Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Yale University School of Medicine, CMHC/SAC, Suite S206, 34 Park St., New Haven, CT 06519.
    • ,
  • David E. Moody, Ph.D.

      Affiliations

    • Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA
    • ,
  • Juliana Pakes, M.S.

      Affiliations

    • Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    • ,
  • Patrick G. O'Connor, M.D.

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
    • ,
  • Richard S. Schottenfeld, M.D.

      Affiliations

    • Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

Received 7 March 2005 ,Revised 6 May 2005 ,Accepted 23 August 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0740-5472(05)00173-X

doi: 10.1016/j.jsat.2005.08.011

Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 307-312 , December 2005

Article Tools

* Image Usage & Resolution